Effect of fluoxetine on dexamethasone-induced growth hormone release in depression: a double-blind, placebo-controlled study
Abstract
OBJECTIVE: The authors' objective was to characterize the effects of fluoxetine treatment on dexamethasone-induced growth hormone (GH) responses in depressed patients. METHOD: Twelve patients (six women and six men) with major depression diagnosed according to DSM-III-R underwent dexamethasone-induced GH stimulation before and after random assignment to 4 weeks of treatment with either placebo (N = 6) or fluoxetine (N = 6). RESULTS: All six patients treated with fluoxetine and two of the six patients given placebo demonstrated an increase in their dexamethasone-induced GH responses. CONCLUSIONS: Clinical recovery was associated with an increase in GH release in response to dexamethasone.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
